Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17474539rdf:typepubmed:Citationlld:pubmed
pubmed-article:17474539lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0021658lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0907402lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0010181lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0679083lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0039021lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:17474539lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:17474539pubmed:issue4lld:pubmed
pubmed-article:17474539pubmed:dateCreated2007-5-3lld:pubmed
pubmed-article:17474539pubmed:abstractTextThe objective of this study was to evaluate the cost-effectiveness of insulin glargine compared with NPH insulin in patients with type 2 diabetes and in whom OAD (oral anti-diabetics) had failed in Switzerland.lld:pubmed
pubmed-article:17474539pubmed:languageenglld:pubmed
pubmed-article:17474539pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:citationSubsetIMlld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17474539pubmed:statusMEDLINElld:pubmed
pubmed-article:17474539pubmed:monthAprlld:pubmed
pubmed-article:17474539pubmed:issn0946-1965lld:pubmed
pubmed-article:17474539pubmed:authorpubmed-author:GreinerR ARAlld:pubmed
pubmed-article:17474539pubmed:authorpubmed-author:BrändleMMlld:pubmed
pubmed-article:17474539pubmed:authorpubmed-author:AzoulayMMlld:pubmed
pubmed-article:17474539pubmed:issnTypePrintlld:pubmed
pubmed-article:17474539pubmed:volume45lld:pubmed
pubmed-article:17474539pubmed:ownerNLMlld:pubmed
pubmed-article:17474539pubmed:authorsCompleteYlld:pubmed
pubmed-article:17474539pubmed:pagination203-20lld:pubmed
pubmed-article:17474539pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:meshHeadingpubmed-meshheading:17474539...lld:pubmed
pubmed-article:17474539pubmed:year2007lld:pubmed
pubmed-article:17474539pubmed:articleTitleCost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the Diabetes Mellitus Model in patients with type 2 diabetes in Switzerland.lld:pubmed
pubmed-article:17474539pubmed:affiliationDivision of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St. Gallen, Switzerland. Michael.Braendle@kssg.chlld:pubmed
pubmed-article:17474539pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17474539pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:17474539pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17474539pubmed:publicationTypeEvaluation Studieslld:pubmed